GLP-1s May Lead to an Increased Risk of Post-Endoscopy Aspiration Pneumonia by ColoWrap, on May 15, 2024 In a recent large population-based study published in the peer-reviewed Gastroenterology journal, researchers found that glucagon-like peptide-1 receptor agonist (GLP-1RA) medicationssuch as Ozempic and Wegovy that are integrally transforming medications in the management of type 2 diabetes and obesityare associated with a higher risk of post-endoscopy aspiration pneumonia
Zhengqiu Yu (Xiamen University, China), Dr
Until more data emerges, they remain a future possibility, not a current option
The publication reported the estimated mean percent change in body weight from baseline to week 68 for each arm, with the combination arm showing a substantially larger estimated reduction than placebo, and the cagrilintide-alone arm showing an intermediate reduction
Clinical Reviews in Allergy and Immunology
Compared with placebo or other interventions, GLP-1 receptor agonists use showed an association with an increased risk of overall thyroid disorders (RR 1.28, 95% CI 1.03-1.60)
